Jens-Peter Marschner
1PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (1)
Sort by Publication Date:
|Dec 23, 2022
ATX-101, a cell-penetrating protein targeting PCNA, can be safely administered as intravenous infusion in patients and shows clinical activity in a Phase 1 study.Charlotte Rose Lemech, Ganessan Kichenadasse, Jens-Peter Marschner
Pageof 1
